Analysis of patent applications relating to peroxisome proliferator-activated receptor (PPAR) ligands in 2004

Chemical Compounds

• Ligand 36%
• Antitriglyceride 36%
• Peroxisome Proliferator Activated Receptor Agonist 36%
• Metabolic 33%
• Application 25%
• Lipoprotein 22%
• High Throughput Screening 22%
• Structure-Activity Relationship 17%
• Glucose 15%
• Lipid 14%

Medicine & Life Sciences

• Peroxisome Proliferator-Activated Receptors 100%
• Ligands 58%
• Homeostasis 11%
• High-Throughput Screening Assays 10%
• Fibric Acids 10%
• Thiazolidinediones 9%
• Structure-Activity Relationship 8%
• Cytoplasmic and Nuclear Receptors 7%
• Dyslipidemias 7%
• Lipoproteins 7%
• Obesity 5%
• Pharmacology 5%
• Lipids 4%
• Glucose 4%
• Therapeutics 2%